HSP90AA1 and neoplasm: Following this subgrouping, we were willing to elucidate the relationship between HSP90α levels and baseline characteristics in different subgroups, demonstrating that patients with high HSP90α plasma levels were significantly associated with worse tumor burden and more aggressive BCLC staging (Supplementary Tables 3–8).